22nd Century Group Inc (XXII)

[Atlanta1]

Investment Summary:
We expect meaningful revenues to begin from product sales of the company’s proprietary RED SUN and MAGIC
brands. Over the longer-term 22nd Century will pursue the $1 billion US smoking-cessation market with its proprietary
X-22 cigarette, and will file with the FDA applications for modified risk cigarettes.

The value of this technology was validated by BAT in October of 2013 when it signed a worldwide research license
agreement with 22nd Century. The company received a $7 million payment in Q4 of 2013. BAT has the option to turn
this research license into a royalty-bearing commercial license at any time.

$XXII